These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 16611118)

  • 21. Identification of a Novel Small Molecule Inhibitor Against SARS Coronavirus Helicase.
    Cho JB; Lee JM; Ahn HC; Jeong YJ
    J Microbiol Biotechnol; 2015 Dec; 25(12):2007-10. PubMed ID: 26387819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Halogenated benzimidazoles and benzotriazoles as inhibitors of the NTPase/helicase activities of hepatitis C and related viruses.
    Borowski P; Deinert J; Schalinski S; Bretner M; Ginalski K; Kulikowski T; Shugar D
    Eur J Biochem; 2003 Apr; 270(8):1645-53. PubMed ID: 12694177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure and function of hepatitis C virus NS3 helicase.
    Kwong AD; Kim JL; Lin C
    Curr Top Microbiol Immunol; 2000; 242():171-96. PubMed ID: 10592661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The helicase-primase inhibitor BAY 57-1293 reduces the Alzheimer's disease-related molecules induced by herpes simplex virus type 1.
    Wozniak MA; Frost AL; Itzhaki RF
    Antiviral Res; 2013 Sep; 99(3):401-4. PubMed ID: 23867133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations close to functional motif IV in HSV-1 UL5 helicase that confer resistance to HSV helicase-primase inhibitors, variously affect virus growth rate and pathogenicity.
    Biswas S; Tiley LS; Zimmermann H; Birkmann A; Field HJ
    Antiviral Res; 2008 Oct; 80(1):81-5. PubMed ID: 18539344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herpes simplex virus helicase-primase inhibitors: recent findings from the study of drug resistance mutations.
    Biswas S; Field HJ
    Antivir Chem Chemother; 2008; 19(1):1-6. PubMed ID: 18610552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of herpes simplex virus replication by a 2-amino thiazole via interactions with the helicase component of the UL5-UL8-UL52 complex.
    Spector FC; Liang L; Giordano H; Sivaraja M; Peterson MG
    J Virol; 1998 Sep; 72(9):6979-87. PubMed ID: 9696789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methods for detecting ATP hydrolysis and nucleic acid unwinding of Japanese encephalitis virus NS3 helicase.
    Fang J; Li H; Peng G; Cao S; Zhen FF; Chen H; Song Y
    J Virol Methods; 2013 Dec; 194(1-2):33-8. PubMed ID: 23948158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicase primase inhibitors (HPIs) are efficacious for therapy of human herpes simplex virus (HSV) disease in an infection mouse model.
    Uhlig N; Donner AK; Gege C; Lange F; Kleymann G; Grunwald T
    Antiviral Res; 2021 Nov; 195():105190. PubMed ID: 34666109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents.
    Spratt AN; Gallazzi F; Quinn TP; Lorson CL; Sönnerborg A; Singh K
    Expert Opin Ther Pat; 2021 Apr; 31(4):339-350. PubMed ID: 33593200
    [No Abstract]   [Full Text] [Related]  

  • 31. Tropolone and its derivatives as inhibitors of the helicase activity of hepatitis C virus nucleotide triphosphatase/helicase.
    Borowski P; Lang M; Haag A; Baier A
    Antivir Chem Chemother; 2007; 18(2):103-9. PubMed ID: 17542155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of the functions of the putative metal-binding domain of the SCV helicase.
    Huang JD; Sun HZ; Tanner JA; Watt RM
    Hong Kong Med J; 2009 Oct; 15 Suppl 6():15-6. PubMed ID: 19801711
    [No Abstract]   [Full Text] [Related]  

  • 33. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
    Lescar J; Luo D; Xu T; Sampath A; Lim SP; Canard B; Vasudevan SG
    Antiviral Res; 2008 Nov; 80(2):94-101. PubMed ID: 18674567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor.
    Yajima M; Yamada H; Takemoto M; Daikoku T; Yoshida Y; Long T; Okuda T; Shiraki K
    Antiviral Res; 2017 Mar; 139():95-101. PubMed ID: 28027917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. West Nile Virus NS2B/NS3 protease as an antiviral target.
    Chappell KJ; Stoermer MJ; Fairlie DP; Young PR
    Curr Med Chem; 2008; 15(27):2771-84. PubMed ID: 18991636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs in development for herpes simplex and varicella zoster virus.
    Birkmann A; Zimmermann H
    Clin Pharmacol Ther; 2017 Jul; 102(1):30-32. PubMed ID: 28160282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-based virtual screening for novel inhibitors of Japanese encephalitis virus NS3 helicase/nucleoside triphosphatase.
    Kaczor A; Matosiuk D
    FEMS Immunol Med Microbiol; 2010 Feb; 58(1):91-101. PubMed ID: 19863664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).
    Borowski P; Heising MV; Miranda IB; Liao CL; Choe J; Baier A
    Biochem Pharmacol; 2008 Jul; 76(1):28-38. PubMed ID: 18479669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New antiviral drugs that target herpesvirus helicase primase enzymes.
    Kleymann G
    Herpes; 2003 Aug; 10(2):46-52. PubMed ID: 14577954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of virus strains resistant to the herpes virus helicase-primase inhibitor ASP2151 (Amenamevir).
    Chono K; Katsumata K; Kontani T; Shiraki K; Suzuki H
    Biochem Pharmacol; 2012 Aug; 84(4):459-67. PubMed ID: 22687623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.